Genistin


Literature identifierStudy typeTest dosageEffective dosageEndocrine-mediated endpointsSystems-level perturbations
PMID:20049207IVR12.5 mg/kg/day 12.5 mg/kg/dayAffects survival of live fetusReproductive endocrine-mediated perturbations
IVR37.5 mg/kg/day 37.5 mg/kg/dayAffects differentiation processDevelopmental endocrine-mediated perturbations
IVR37.5 mg/kg/day 37.5 mg/kg/dayPregnancy complicationsReproductive endocrine-mediated perturbations
IVR37.5 mg/kg/day 37.5 mg/kg/dayIncreased uterine weightsReproductive endocrine-mediated perturbations
IVR37.5 mg/kg/day 37.5 mg/kg/dayAlterations in vaginal openingReproductive endocrine-mediated perturbations
IVR37.5 mg/kg/day 37.5 mg/kg/dayAffects survival of live fetusReproductive endocrine-mediated perturbations
IVR37.5 mg/kg/day 37.5 mg/kg/dayAbnormal estrous cyclesReproductive endocrine-mediated perturbations
IVR6.25 mg/kg/day -No significant effects observed-
IVR25 mg/kg/day 25 mg/kg/dayIncreased uterine weightsReproductive endocrine-mediated perturbations
IVR25 mg/kg/day 25 mg/kg/dayAbnormal estrous cyclesReproductive endocrine-mediated perturbations
IVR25 mg/kg/day 25 mg/kg/dayAffects survival of live fetusReproductive endocrine-mediated perturbations

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.